Darolutamide
BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

The pharmaceutical sector saw several significant deals with major players expanding their portfolios. Bristol Myers Squibb (BM...

Impressions : 826

US Senate passes bipartisan bill to cut pharma patent abuses; Ipsen inks another ADC deal

US Senate passes bipartisan bill to cut pharma patent abuses; Ipsen inks another ADC deal

This week, a bill heralded as “critical” to help “end anti-competitive practices” was passed by the US ...

Impressions : 1509